avapritinib,regorafenib
blueprint medicines
['voyager', 'sarcoma', '#gi']
on the ground at #asco22: vhio s speaks to about the ctdna analyses of the phase 3 voyager trial. data show that ctdna sequencing correlates with outcomes in #gist #sarcoma. 
Leading translational research to accelerate & advance personalized and targeted therapies against cancer. 
@iCERCA centre